Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using a wearable vest to measure lung fluid in heart failure patients

Official title: Remote Dielectric Sensing Technology Guided Diuresis in Hospitalized Patients With Acute Decompensated Heart Failure

Run by University of California, San Francisco · NCT03586336 · Data updated 2026-11-12

This study is testing a new wearable vest that measures lung fluid in heart failure patients to see if it can help them get better treatment compared to standard care.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedDecember 1, 2018
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 2, 2026
Trial IDNCT03586336 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are hospitalized adults with acute decompensated heart failure who require intravenous diuretics or vasoactive drugs.

Probably not a fit

Patients with chronic renal failure, significant lung issues, or those requiring inotropic support may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a wearable vest that non-invasively measures lung fluid content in hospitalized patients suffering from acute decompensated heart failure. The approach involves using Remote Dielectric Sensing (ReDS) technology to guide diuresis treatment, which is traditionally managed through less reliable clinical methods. Patients will be randomly assigned to either receive ReDS-guided treatment or usual care, with daily measurements taken for all participants. The goal is to determine if ReDS can improve patient outcomes by providing more accurate assessments of fluid status.

Why it matters

Potential benefit: If successful, this approach could lead to more effective management of fluid overload in heart failure patients, potentially reducing hospital stays and improving recovery times.

How similar studies have gone: Other studies utilizing non-invasive monitoring technologies have shown promise, suggesting that this approach could be beneficial, though the specific use of ReDS in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients hospitalized for acute decompensated heart failure requiring treatment with intravenous diuretics and/or IV vasoactive drugs
* Patient has signed informed consent and has authorized use and disclosed health information
* Patient is at least 18 years of age
* Patient physically suitable for ReDS measurement
* GFR\>25
* Initial ReDS Measurement \>35%

Exclusion Criteria:

* Patient characteristics excluded from approved use of ReDS system: height less than 155cm or greater than 190cm, BMI \<22 or \>39, chest circumference \<80cm or \>115cm , or flail chest
* Evidence of focal lung lesions on history, physical exam or chest x-ray, including history of pulmonary embolism, active pneumonia, or known lung nodule
* Chronic renal failure (GFR\<25)
* Prior cardiac surgery within 2 months of index admission
* Patient has a ventricular assist device or has had a cardiac transplantation
* Patients in cardiogenic shock at admission requiring inotropic support
* Congenital heart malformations or intra-thoracic mass that would affect right-lung anatomy (e.g dextrocardia, lung carcinoma, or pacemaker box in the right chest)

Where it's running

  • University of California, San Francisco
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Liviu Klein, MD, MS — Director, Mechanical Circulatory Support and Heart Failure Device Program
  • Study coordinator: Cynthia Partida-Higuera
  • Email: Cynthia.Partida-Higuera@ucsf.edu
  • Phone: 415-514-1125

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.